Dr. Antony Ruggeri
Claim this profileAurora Cancer Care-Milwaukee West
Studies Cancer
Studies Colorectal Cancer
14 reported clinical trials
57 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Colorectal Cancer
Stage IV
Stage III
BRAF negative
Affiliated Hospitals
Clinical Trials Antony Ruggeri is currently running
Fulvestrant + Binimetinib
for Breast Cancer
This trial is testing whether adding binimetinib to the usual treatment of fulvestrant can help patients with a specific type of advanced breast cancer. Fulvestrant works by blocking estrogen receptors on cancer cells, while binimetinib stops enzymes that help cancer grow. The goal is to see if this combination can better control the cancer compared to using fulvestrant alone.
Recruiting1 award Phase 219 criteria
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
More about Antony Ruggeri
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Antony Ruggeri has experience with
- Paclitaxel
- Olaparib
- Fluorouracil
- Capecitabine
- Cisplatin
- Regorafenib
Breakdown of trials Antony Ruggeri has run
Cancer
Colorectal Cancer
Solid Tumors
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antony Ruggeri specialize in?
Antony Ruggeri focuses on Cancer and Colorectal Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Antony Ruggeri currently recruiting for clinical trials?
Yes, Antony Ruggeri is currently recruiting for 8 clinical trials in Wauwatosa Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Antony Ruggeri has studied deeply?
Yes, Antony Ruggeri has studied treatments such as Paclitaxel, Olaparib, Fluorouracil.
What is the best way to schedule an appointment with Antony Ruggeri?
Apply for one of the trials that Antony Ruggeri is conducting.
What is the office address of Antony Ruggeri?
The office of Antony Ruggeri is located at: Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin 53226 United States. This is the address for their practice at the Aurora Cancer Care-Milwaukee West.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.